Lunpo Wu
Department of Gastroenterology
Second Affiliated Hospital of Zhejiang University School of Medicine
Lunpo Wu is a physician in Gastroenterology Department at 2nd Affiliated Hospital of Zhejiang University School of Medicine. She received her Doctor degree of Medicine from Zhejiang University in 2020 and completed her resident training in Second Affiliated Hospital of Zhejiang Medical University.
During Dr. Wu’s training, she developed a keen focus on research that encompasses maintenance of Oncology. Her main research field is screening and identification of mainly molecular modification and targets in the carcinogenesis of gastrointestinal disease, as well as the clinical research on oncology disease (epidemiology, survival analysis, clinical model and so on)
Clinical Nomogram for Predicting Survival Outcomes in Early Mucinous Breast Cancer.
PloS one , 2016 | Pubmed ID: 27760180
Signet ring cell carcinoma of resectable metastatic colorectal cancer has rare surgical value.
Journal of surgical oncology Dec, 2016 | Pubmed ID: 27891617
Survival outcomes and surgical intervention of small intestinal neuroendocrine tumors: a population based retrospective study.
Oncotarget Jan, 2017 | Pubmed ID: 27903960
Real-world impact of non-breast cancer-specific death on overall survival in resectable breast cancer.
Cancer Jul, 2017 | Pubmed ID: 28267199
How Young Is Too Young in Breast Cancer?-Young Breast Cancer Is Not a Unique Biological Subtype.
Clinical breast cancer 02, 2018 | Pubmed ID: 28802528
The Lymph Node Ratio Optimizes Staging in Patients with Small Intestinal Neuroendocrine Tumors.
Neuroendocrinology , 2018 | Pubmed ID: 29920478
Young Patients with Hormone Receptor-Positive Breast Cancer Have a Higher Long-Term Risk of Breast Cancer Specific Death.
Journal of breast cancer Mar, 2019 | Pubmed ID: 30941237
Young-onset breast cancer: a poor prognosis only exists in low-risk patients.
Journal of Cancer , 2019 | Pubmed ID: 31289582
De-escalating chemotherapy for stage II colon cancer?
Therapeutic advances in gastroenterology , 2019 | Pubmed ID: 31489031
Klotho-mediated targeting of CCL2 suppresses the induction of colorectal cancer progression by stromal cell senescent microenvironments.
Molecular oncology 11, 2019 | Pubmed ID: 31545552
Zic1 suppresses gastric cancer metastasis by regulating Wnt/β-catenin signaling and epithelial-mesenchymal transition.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 02, 2020 | Pubmed ID: 31909528
Early T Stage Is Associated With Poor Prognosis in Patients With Metastatic Liver Colorectal Cancer.
Frontiers in oncology , 2020 | Pubmed ID: 32626650
Establishing a Competing Risk Regression Nomogram Model for Survival Data
1Department of Gastroenterology, Second Affiliated Hospital of Zhejiang University School of Medicine,
2Institute of Gastroenterology, Zhejiang University,
3Department of Colorectal Surgery, Afiliated Jinhua Hospital, Zhejiang University School of Medicine,
4Department of Medical Oncology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine,
5Department of Hepatobiliary Pancreatic Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine,
6Division of Oncology, Johns Hopkins University School of Medicine
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有，本公司不涉及任何医疗业务和医疗服务。